Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114M
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
15.8M
-
Shares change
-
-2.83M
-
Total reported value, excl. options
-
$28.4M
-
Value change
-
-$9.46M
-
Number of buys
-
21
-
Number of sells
-
-23
-
Price
-
$1.80
Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2016
53 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2016.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.8M shares
of 114M outstanding shares and own 13.8% of the company stock.
Largest 10 shareholders include FMR LLC (4.31M shares), Polaris Venture Management Co. V, L.L.C. (2.47M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (2.26M shares), Redmile Group, LLC (1.49M shares), ORBIMED ADVISORS LLC (693K shares), VANGUARD GROUP INC (635K shares), FRANKLIN RESOURCES INC (500K shares), Belmont Global Advisors, Inc. (482K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (475K shares), and PRINCIPAL FINANCIAL GROUP INC (294K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.